Weight Management Classes

PCOS Relief's 12-week weight management program helps women with PCOS fight weight gain through exercise options for all fitness levels (Indoor or Outdoor, Cardio, Strength).

One of the major health condition a female can experience when being diagnosed with PCOS is the challenge with weight, this can be Obesity, stubborn fats, bloating and the difficulty with losing weight.

At PCOS Relief, we understand, having access to weight management support will assist you in self managing your conditions.

Therefore, here at PCOS Relief, we will focus on the below in order to support females managing their weight struggles as well as their condition.

At PCOS Relief, we run a 12-week Weight Management programme, and in those 12 weeks, we will focus on the following:
In-door and Outdoor Activities
Strengthen
Cardio
Muscular Endurance
Stretches
Exercising at Home
How to work out on the go
Weights

Classes will run from Monday to Saturday allowing everyone to attend one class each week that is suitable for them for the next 12 weeks.

Avatar photoAvatar photoAvatar photo

Seeking Support? Start Your PCOS Journey Now

Explore a wealth of resources and a supportive community dedicated to empowering you on your PCOS journey. Join us today.
Official update · May 2026

A landmark update
for 170 million
women worldwide

Previously PCOS Polycystic Ovary Syndrome
Now officially PMOS Polyendocrine Metabolic Ovarian Syndrome

Published in The Lancet, May 2026 · Endorsed by the Endocrine Society · 56 global organisations

What was PCOS?

A hormonal condition named after the appearance of follicles on the ovaries — a term widely recognised as inaccurate, leading to delayed diagnoses and misunderstood care for millions.

What is PMOS?

A complex, long-term condition involving multiple hormone imbalances, metabolic effects like insulin resistance, and impacts on reproductive, mental, and cardiovascular health — far beyond just the ovaries.

After a decade-long global study with 22,000+ patients and clinicians, the new name was published in The Lancet to reduce diagnostic delays affecting up to 70% of women living with this condition.

Take Survey